VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
SPNT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
SPNTSiriusPoint Ltd.
$23.97$2.8B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksSPNTQuarterly Financials

SiriusPoint Ltd. (SPNT) Quarterly Financials

120+ quarters historyFree accessUpdated daily

SiriusPoint Ltd. (SPNT) quarterly income statement — complete revenue, gross profit & net income history

SPNT Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Revenue774.6M973.7M753.5M731.5M729.4M625.7M559.2M739.7M688.9M626.6M704.4M693.4M678M612.1M649.1M529.6M380.8M463M748.7M549.5M
Revenue Growth %6.2%55.62%34.75%-1.11%5.88%-0.14%-20.61%6.68%1.61%2.37%8.52%30.93%78.05%32.2%-13.3%-3.62%-23.99%22.34%190.42%97.09%
Medical Costs & Claims362.9M372.2M512.7M513.5M531.5M503.7M435M484.3M462.4M477.1M502.6M487.5M0503.1M614.7M483.9M448.6M447.9M684.2M356.5M
Medical Cost Ratio %46.85%38.23%68.04%70.2%72.87%80.5%77.79%65.47%67.12%76.14%71.35%70.31%0%82.19%94.7%91.37%117.8%96.74%91.39%64.88%
Gross Profit411.7M601.5M240.8M218M197.9M122M124.2M255.4M226.5M149.5M201.8M205.9M678M109M34.4M45.7M-67.8M15.1M64.5M193M
Gross Margin %53.15%61.77%31.96%29.8%27.13%19.5%22.21%34.53%32.88%23.86%28.65%29.69%100%17.81%5.3%8.63%-17.8%3.26%8.61%35.12%
Gross Profit Growth %108.03%393.03%93.88%-14.64%-12.63%-18.39%-38.45%24.04%-66.59%37.16%486.63%350.55%1100%621.85%-46.67%-76.32%-123.78%-90.02%-30.27%32.19%
Operating Expenses290.2M321.3M129.9M143.1M122.7M134.6M113.1M126.4M121.2M151.4M122.7M128.2M678M151.6M127.1M129.5M135.8M131.5M124.9M113.3M
OpEx / Revenue %37.46%33%17.24%19.56%16.82%21.51%20.23%17.09%17.59%24.16%17.42%18.49%100%24.77%19.58%24.45%35.66%28.4%16.68%20.62%
Depreciation & Amortization2.6M02.8M2.8M2.9M3M3M3M2.9M2.9M2.9M2.9M2.4M3.8M2.1M2M1.9M3.4M3.5M2.8M
Combined Ratio %84.31%71.22%85.28%89.76%89.69%102.01%98.02%82.56%84.71%100.3%88.77%88.79%100%106.96%114.28%115.82%153.47%125.14%108.07%85.5%
Operating Income121.5M280.2M110.9M74.9M75.2M-12.6M11.1M129M105.3M-1.9M79.1M77.7M0-42.6M-92.7M-83.8M-203.6M-116.4M-60.4M79.7M
Operating Margin %15.69%28.78%14.72%10.24%10.31%-2.01%1.98%17.44%15.29%-0.3%11.23%11.21%0%-6.96%-14.28%-15.82%-53.47%-25.14%-8.07%14.5%
Operating Income Growth %61.57%2323.81%899.1%-41.94%-28.59%-563.16%-85.97%66.02%-95.54%185.33%192.72%100%63.4%-53.48%-205.14%-213.3%-184.05%-187.03%-37.39%
EBITDA124.1M299.7M113.7M77.7M78.1M-9.6M14.1M132M108.2M1M82M80.6M179M-38.8M-90.6M-81.8M-201.7M-113M-56.9M82.5M
EBITDA Margin %16.02%30.78%15.09%10.62%10.71%-1.53%2.52%17.85%15.71%0.16%11.64%11.62%26.4%-6.34%-13.96%-15.45%-52.97%-24.41%-7.6%15.01%
Interest Expense16.8M19.5M21M21.1M18.1M19.6M13.8M15.7M20.5M19.8M19.8M11.7M12.8M10.5M9.4M9.4M9.3M9.6M9.7M9.8M
Non-Operating Income-16.8M-19.4M-21M-21.1M-18.2M-19.6M-13.8M-15.7M-20.8M-19.8M-19.8M-11.7M-176.6M-10.5M-9.4M-9.4M-9.3M-9.6M-9.7M-9.8M
Pretax Income121.5M280.2M110.9M74.9M75.3M-12.6M11.1M129M105.6M-1.9M79.1M77.7M163.8M-42.6M-92.7M-83.8M-203.6M-116.4M-60.4M79.7M
Pretax Margin %15.69%28.78%14.72%10.24%10.32%-2.01%1.98%17.44%15.33%-0.3%11.23%11.21%24.16%-6.96%-14.28%-15.82%-53.47%-25.14%-8.07%14.5%
Income Tax19.2M36.1M20.2M11.6M13.3M4.4M2.4M14.2M9.7M-101.6M15.3M15.8M25.5M-19.6M900K-27.7M9.7M-17.1M-13M9.6M
Effective Tax Rate %15.8%12.88%18.21%15.49%17.66%-34.92%21.62%11.01%9.19%5347.37%19.34%20.33%15.57%46.01%-0.97%33.05%-4.76%14.69%21.52%12.05%
Net Income102.2M244M90.8M63.2M61.6M-17.3M8.5M113.9M94.8M97.5M61.5M59.9M135.9M-21.8M-94.4M-56.8M-213M-98.8M-44M68.5M
Net Margin %13.19%25.06%12.05%8.64%8.45%-2.76%1.52%15.4%13.76%15.56%8.73%8.64%20.04%-3.56%-14.54%-10.73%-55.93%-21.34%-5.88%12.47%
Net Income Growth %65.91%1510.4%968.24%-44.51%-35.02%-117.74%-86.18%90.15%-30.24%547.25%165.15%205.46%163.8%77.94%-114.55%-182.92%-225.37%-173.51%-164.05%-44.76%
EPS (Diluted)0.731.970.730.500.45-0.110.030.570.490.540.340.370.80-0.14-0.58-0.35-1.33-0.86-0.270.37
EPS Growth %62.22%1890.91%2707.69%-12.28%-8.16%-120.37%-92.35%54.05%-38.75%485.71%158.62%205.71%160.15%83.72%-114.81%-194.59%-198.52%-160.14%-136.99%-72.18%
EPS (Basic)0.762.060.740.510.50-0.110.030.600.500.560.350.380.82-0.14-0.58-0.35-1.34-0.87-0.280.37
Diluted Shares Outstanding121.84M121.84M118.82M161.38M161.38M161.38M172.8M178.71M174.38M173.61M168.52M166.71M164.13M160.46M160.32M160.26M159.87M159.27M160.24M160.89M